
Amir Nashat
@vcamir
General Partner at Polaris Partners. Focus includes healthcare, consumer products and energy.
ID: 1009408812
http://www.polarispartners.com/team/member/amir-nashat/ 13-12-2012 18:18:47
871 Tweet
2,2K Followers
225 Following


IPI is officially fighting #COVID-19 with #SyntheticPeptides that neutralize #SARS-CoV-2 incorporated into engineered #nanostructures for use in disinfecting aerosols. Congrats to IPI’s Chris Bahl and Phil Demokritou Harvard T.H. Chan School of Public Health for scoring @NSFgrant.


BIDMC proud: research led by Dan Barouch, MD, PhD, Director of Virology and Vaccine Research, is on the front page of both the The Boston Globe and The New York Times today. Learn more about the #COVID19 vaccine prototypes making headlines: bit.ly/3cNDAMx










1) There is a lot of talk about decaying antibodies. I would like to walk you through a few findings about antibodies to SARS-CoV-2 that we put on medRxiv on Friday. Ill do this slowly over the day (while being in nonstop conference calls). But I feel this needs to get out there.

Proud of Polaris companies SQZBiotech Glympse Bio and Dewpoint Therapeutics for being included amongst amazing companies, entrepreneurs and visions. We are lucky to be part of an amazing industry!






